On February 22, 2013, Wang Xiping, General Manager of QYAOBIO(ChinaPeptides), and Professor Xu Xun from Shanghai First People's Hospital had an in-depth meeting on a large-scale peptide new drug research and development project in 2013, and the meeting achieved positive results. This peptide new drug development project will start in March 2013.

Over the years, Professor Xu has maintained good cooperation with QYAOBIO(ChinaPeptides), and ChinaPeptides's high-quality peptide products have also been affirmed and praised by Professor Xu.